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The first segregation of cells in the early mammalian embryo generates trophectoderm and 
inner mass cells. The latter will form the future epiblast cells and the primitive endoderm. The 
epiblast cells are a transient population of cells with a remarkable property: they can 
differentiate into all cell lineages of the embryo proper (giving rise to the entire adult 
organism) and a number of cell populations that will form extra-embryonal parts. This 
property of the inner cell mass cells is referred to as ‘pluripotency’. Based mainly on 
experiments with inner cell mass like cells in vitro, i.e. embryonic stem cells, preserving it 
requires maintenance of self-renewal and inhibition of differentiation. Defining the molecular 
mechanisms and factors that control the initiation, maintenance and exit from pluripotency 
(which accompanies the onset of cell differentiation) is crucial in order to have a better 
understanding of early development. In addition to fundamental insights in development, 
pluripotent cells can be used to generate knockout or transgenic animals (through embryonic 
stem cells). In principle, these cells are also a cell source for cell therapy in regenerative 
medicine or personalized disease models (through induced pluripotent cells, which are 
obtained from somatic cells via reprogramming, and which are similar to pluripotent 
embryonic stem / epiblast cells). To fulfil the potential of induced pluripotent cells in 
personalized medicine, it is of fundamental importance to fully characterize pluripotency as it 
occurs in development. This introduction presents an overview of embryonic development, 
the events that generate pluripotency, the transition from one type of pluripotency to 
another, the signaling pathways involved in these processes and their molecular effects.  
The core characteristics of pluripotent cells and their potential for developmental biology, 
regenerative medicine and establishment of tumor-initiating cells by cell de-differentiation in 
cancer have generated tremendous interest in understanding the molecular mechanisms 
controlling them. Although significant progress has been made in the past years in elucidating 
the cell extrinsic and intrinsic factors that regulate self-renewal and pluripotency, several 
major gaps still remain. In particular, this introduction provides an overview of the known 
mechanisms either triggered or inhibited by various signals which seemingly have opposing 
effects on the molecular machinery affecting pluripotency, depending on the particular 
developmental stage of the cells. This represents the crucial context in which the work 
presented in this thesis must be viewed from.  
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This thesis enriches the body of knowledge around pluripotency by describing a novel 
pluripotent state. It deepens our understanding of cell biology, the processes establishing 
pluripotency and provides new insights into improving the process of artificial generation of 
pluripotent cells.  
1. The establishment and dismantling of pluripotency during 
embryogenesis 
Vertebrate development starts after an egg is fertilized by a sperm cell. Although on a different 
time scale, the processes described in this section are similar between mice and humans. Both 
the egg cell and the sperm cell carry half of the genetic information of the parent they 
originate from. Upon fertilization, the nuclei of the two cells merge and thus lead to the 
formation of a single diploid cell: the zygote. The zygote can give rise to a whole embryo, as 
well as extra-embryonic tissues, like the placenta in mammals. Therefore, it is totipotent. At 
this stage, the proteins that wrap and condense the DNA still have modifications inherited 
from the parents (epigenetic marks, for example the methylation of histones that wrap the 
DNA). After four rounds of cell division with no significant growth, a process called cleavage, 
the embryo advances to a ball of 16 cells called a morula. During these stages, cells go through 
a process in which the epigenetic marks are removed. In mouse, 3 days after fertilization 
(embryonic day 3 or E3), the cells go through their first specification, answering to cues from 
 
Figure 1. Schematic representation of peri-implantation embryo development in mouse and human. Adapted 
from (Smith A. , 2017). 
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neighboring cells that inform them, in part based on their relative position, on their position 
within the embryo (Krupa, et al., 2014). In the morula stage, a phenomenon unique to 
mammalian embryos occurs, compaction.  This change in shape of the embryo leads to the 
formation of an outer layer of cells, called trophectoderm, from which extra-embryonic tissues 
will develop, and an inner clump of cells, the inner cell mass (ICM) (Morris, et al., 2010). Fluid 
collects between the trophoblast and the ICM, and following a cavitation process the morula 
transitions into a blastocyst (figure 1).  
The cells in the ICM segregate into primitive endoderm and the pluripotent epiblast around 
E4 (in mouse) or day 7 of human embryonic development. The epiblast gives rise to all tissues 
of the embryo, a property called pluripotency. It is at this stage that methylation reaches an 
all-developmental low, meaning that the chromatin (DNA and proteins organized as 
chromosomes) is open and all marks inherited from parents have been removed (Smith Z. , et 
al., 2012). The cells are therefore said to be in a naïve pluripotency (Nichols & Smith , 2009). 
Shortly after reaching this step, information by way of cell-cell contacts leads to the gain of 
polarity in these cells and a re-arrangement of them in a rosette, with a basal membrane 
towards the outside and an apical side towards the middle, coinciding with implantation 
(Bedzhov & Zernicka-Goetz, 2014). Here, cells start secreting sialomucins that lead to the 
formation of another cavity, which expands until the epiblast cells form the egg cylinder 
(figure 2). The egg cylinder is a unique feature of mouse embryonic development. 
After having went through 2 rounds of specification and in preparation to the next step, which 
is differentiation to one of the three germ layers, the cells that form the epiblast start 
undergoing epigenetic changes that enable the cells to undertake stable differentiation. 
 
Figure 2. Schematic representation of mouse peri-implantation development. Adapted from (Bedzhov & 
Zernicka-Goetz, 2014) 
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Because they still have the potential to differentiate into any cell type, depending on the 
signaling cues they receive, these cells are also pluripotent. As opposed to the cells in the ICM, 
due to their more advanced development, these cells are in a primed pluripotent state. The 
two types of pluripotency and their characteristics will be discussed in the following sections. 
The next developmental event after the formation of the egg cylinder is gastrulation. 
Gastrulation is a crucial stage in embryonic development, when pluripotent epiblast cells 
organize to generate the germ layers: mesendoderm (initially, later yielding mesoderm and 
definitive endoderm) and ectoderm. Gastrulation strongly rearranges these germ layers and 
lays down the basic, primitive body plan, which will further develop into the embryo. It starts 
approximately at E6.25 with (i) embryonic asymmetry (specification across the proximal-distal 
and anterior-posterior axes), (ii) the formation of the primitive streak, (iii) epithelial to 
mesenchymal transitions and (iv) an ingression at the primitive streak that will form the germ 
layers. Gastrulation is a process that continues for several days. The exit from pluripotency 
and early cell determination in the three germ layers of the embryo proper is guided by several 
signaling pathways, including additional interactions at the extra-embryonal and embryonal 
interface, at the future anterior (no primitive streak formation here) and posterior 
(gastrulation side, visible by primitive streak formation) side of the egg cylinder.   
2. Naïve pluripotency - Embryonic stem cells 
In 1981, Evans and Kaufman were the first ones to succeed in the in vitro derivation of mouse 
pluripotent stem cell lines, from the ICM of blastocysts (Evans & Kaufman, 1981). In the same 
year, Martin coined the term “embryonic stem cells” (Martin, 1981). It has been shown by 
clonal derived cell culture that the capacity of ICM cells to self-renew as embryonic stem cells 
is gained immediately following epiblast specification (Boroviak, Loos, Bertone, Smith, & 
Nichols, 2014). These first lines had a high degree of instability due to their culture conditions 
(i.e. readily differentiating), which were based on a feeder layer of mitotically inactivated 
fibroblasts together with fetal calf serum, with an unknown growth factor composition. A few 
years later, the first factor promoting ESC maintenance was identified by Austin Smith (Smith, 
et al., 1988), and Colin Stewart and collaborators (Williams, et al., 1988), as Leukemia 
Inhibitory Factor (LIF). LIF was demonstrated later as being one of the factors required for the 
maintenance of ESCs (Williams, et al., 1988). Serum, which has a variable and undefined 
composition, was still added to the culture. An important milestone in ESC maintenance was 
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the shift from a serum based medium to a defined, serum free culture. The derivation 
efficiency of ESCs and their stability in culture was shown to be increased by the addition of 
small-molecule inhibitors for MEK signaling (described below) (Burdon, Stracey, Chambers, 
Nichols, & Smith, 1999). This led to the development of several different defined conditions, 
most involving activators of the WNT pathway and MEK inhibitors (most notably three 
inhibitors – 3i, and two inhibitors – 2i) (Kielman, et al., 2002) (Ying, et al., 2008).  Complete 
genetic ablation of Erk1 and Erk2 (MEK effectors), either individually or combined, does not 
lead to a maintenance of rodent ESC survival, nor does it yield an identical phenotype to that 
resulting from MEK inhibition, suggesting that MEK inhibition has additional, ERK-independent 
roles in the maintenance of ESCs (Chen, et al., 2015). In 2011, ten Berge et al. demonstrated 
that in addition to LIF, ESCs only require WNT signals for their homogenous maintenance and 
indefinite expansion (ten Berge, et al., 2011). Other studies contradict this and argue that ESCs 
can be maintained in the absence of WNT signals (Lyashenko, et al., 2011). These findings 
highlight the relevance of investigating ESCs in different combinations of factors or chemical 
inhibitors of their signaling that support the expansion of maintenance of the cells. 
LIF and WNT signaling pathways act to retain the characteristics of ES cells. Morphologically, 
the cells are small and round, and form compact, dome-shaped colonies due to the strong 
adherence of the cells to each other. Upon breaking down a colony in a single cell suspension, 
each individual cell can give rise to a new colony. Their pluripotency can be tested in three 
ways: (i) by injecting the cells subcutaneously, which will lead to the formation of a teratoma 
that contains cell types of all the three germ layers, (ii) by injecting the cells in blastocysts, 
which will lead to the formation of a chimeric embryo, or (iii) by triggering in vitro 
differentiation through embryoid body formation. A fourth, more recent alternative, is to mix 
ESCs with TSCs, thereby generating 3D structures called ETS embryos (ESC- and TSC-derived 
embryos), to show morphogenesis similar to that of natural embryos (Ellys Harrison, Sozen, 
Christodoulou, Kyprianou, & Zernicka-Goetz, 2017).  
Characteristic to these cells is the presence of several pluripotency regulators, which form a 
core pluripotency gene regulatory network. One of the core pluripotency factors is NANOG, 
first reported to be essential for sustaining pluripotency in ESCs (Mitsui, et al., 2003) 
(Chambers, et al., 2003). NANOG-null ESCs cannot be derived from mouse ICM, further 
indicating its indispensable role in establishing pluripotency in vivo (Festuccia, et al., 2012). 
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Another component of the pluripotency gene regulatory network is Octamer-binding 
transcription factor 4 (Oct4, also known as Pou5f1), which is expressed in ESCs and throughout 
the germ line, essential for both in vivo and in vitro pluripotency (Scholer, Hatzopoulos, Balling, 
Suzuku, & Gruss, 1989) (Nichols, et al., 1998) (Niwa, Miyazaki, & Smith, 2000). Upstream of 
OCT4 is SRY-box 2 (SOX2), a transcription factor required for the formation of the pluripotent 
epiblast (Avilion, et al., 2003) (Masui, et al., 2007). The loss of both OCT4 and SOX2 triggers 
differentiation of the cells into trophectoderm, whereas the overexpression of genes encoding 
both proteins leads to the differentiation of mesendoderm or neural ectoderm, respectively 
(Niwa, Miyazaki, & Smith, 2000) (Thomson, et al., 2011). SOX2, OCT4 and NANOG function 
together and co-occupy approximately 14,000  of potential regulatory elements in the 
genome, across approximately 3,200 genes, including their own promoters, forming densely 
interconnected feedback and feedforward regulatory loops (Marson, et al., 2008). Effectors 
of LIF, BMP4 and WNT pathways (STAT3, SMAD1 and β-catenin-TCF7L1, respectively) directly 
modulate the SOX2-OCT4-NANOG core circuit by co-occupying enhancers that are bound by 
these transcription factors (Young, 2011) (Hackett & Surani, 2014). In the absence of nuclear 
β-catenin, TCF7L1 (also known as TCF3) functions as a transcriptional repressor, and 
antagonizes the action of OCT4 and SOX2, which colocalize with TCF7L1 at pluripotency-
associated genes (Cole, Johnstone, Newman, Kagey, & Young, 2008). 
Other ESC-specific markers include alkaline phosphatase, Stella, Klf4, Esrrb, Cd31 (Brons, et 
al., 2007) (Payer, et al., 2006) (Takahashi K. & Yamanaka S., 2006) (Festuccia, et al., 2012) (Li, 
et al., 2005). Their gene expression profile carries a unique signature dependent on the 
pluripotency transcription factors. Epigenetically, their genome can be described as “open”, 
as they have a reduced prevalence of repressive histone markers (H3K27me3) at promoters 
(Marks, et al., 2012). Most of the parental epigenetic marks have been erased and methylation 
reaches an all-developmental low in the ICM and ESCs respectively (Smith Z. , et al., 2012). In 
female cells both X chromosomes are active and repressive histone marks are limited, due to 
a continuous chromatin remodeling (Niwa H. , 2007) (Farthing, et al., 2008). Without inherited 
epigenetic modifications, or modifications that restrict the cells’ future development into one 
of the 3 germ layers, the cells are “naïve” (Ying, et al., 2008).  
Several proteins produced in the ICM or by ESCs do not promote naïve pluripotency. Some of 
them actually promote the transition to primed pluripotency. Due to the highly optimized and 
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defined culture conditions, ESCs tolerate these factors in vitro. For instance, in a defined LIF/2i 
culture, TCF7L1 is neutralized by adding the inhibitor for GSK3, boosting naïve pluripotency 
(Wray, et al., 2011). In LIF/serum conditions, TCF7L1 is able to bind to its naïve pluripotency-
promoting target genes, leading to their partial repression. Thus, the naïve pluripotent state 
is a “zero sum game” representing the outcome of stabilizing and destabilizing factors that act 
in concert (Loh & Lim, 2011). 
3. Naïve to primed pluripotency transition: the formative state 
The in vitro transition from naïve to primed pluripotency consists of a series of key events. In 
vivo, in mouse embryos, the transition from naïve (E3.75-4.75) to primed pluripotency (E6.0-
6.5) covers a time span of approximately 2 days (Boroviak, Loos, Bertone, Smith, & Nichols, 
2014). It was hypothesized that certain events occurring in this time window are essential for 
the transition, but until recently these events had not been described. For instance, cells that 
have lost ES cell identity do not immediately upregulate definitive lineage specification 
markers (Kalkan, et al., 2017). Accordingly, one author coined the term formative to describe 
the transient period between naïve and primed pluripotency (Kalkan & Smith, 2014) (Smith A. 
, 2017).  
A discrete formative phase, intermediate between naïve and primed pluripotency is shown by 
tracking the ESCs’ ability to revert to a naïve state in the absence of exogenous growth factors 
or serum components. Using a destabilized GFP knock-in to the Rex1 locus enables tracking of 
the loss of naïve pluripotency by downregulation of the fluorescent reporter, and screens 
using the REX1-GFP as read-out (Kalkan, et al., 2017). Early after 2i withdrawal (16h), cells 
remain uniformly REX1::GFP-positive and can revert to self-renewal very efficiently. By 25h, 
the GFP expression profile becomes heterogenous: GFP-high cells are still able to self-renew 
if restored to LIF/2i, but this ability is effectively lost in GFP-low. Moreover, the GFP-low 
fraction readily responds to stimuli for the differentiation to the three embryonic germ layers 
(Mulas, Kalkan, & Smith, 2017). An in vitro intermediate state can be captured by culturing 
ESCs in a medium supplemented with FGF and Activin (two key pathways in epiblast stem cell 
maintenance). This leads to epiblast-like cells (EpiLCs), which have a transcriptional state 
similar to the E5.75 epiblast, which is just prior to the onset of gastrulation (Morgani, Nichols, 
& Hadjantonakis, 2017). EpiLCs obtained in vitro show markers of pluripotency that are 
intermediate between ESC and EpiSC: naïve gene markers (e.g. Stella, Rex1 and Klf4) are 
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downregulated, while later markers, associated with differentiation (e.g. T, FoxA2, Lefty, Sox1) 
are not upregulated to the same extent as in EpiSCs, and early EpiSC markers such as Fgf5 and 
Oct6 are expressed at the same or higher levels than in EpiSCs (Morgani, Nichols, & 
Hadjantonakis, 2017). There are several significant differences between the formative phase 
and primed pluripotency, such as the formation of blastocyst chimaeras, germ cell 
competence, lower DNA methylation, expression of genes encoding early post-implantation 
transcription factors and no expression of genes encoding non-ectoderm lineage transcription 
factors (Smith A. , 2017). 
The concept of formative pluripotency acts as a bridge between the two pluripotency states 
captured in vitro, but it is not limited to one cell type in particular. So far, formative 
pluripotency is not a self-renewing state and formative stem cell lines have not yet been 
established. EpiLCs, which may include formative cells, are currently considered as a transient 
type of cells (Hayashi, Ohta, Kurimoto, Aramaki, & Saitou, 2011). Deriving formative 
pluripotent stem cells is a significant challenge which has been suggested to rely on whether 
a stable balance of different signaling pathways exists and can be arrested in vivo (Enver, Pera, 
Peterson, & Andrews , 2009). These states all transiently and seamlessly occur within a 
sequence of developmental progression. 
4. Primed pluripotency - Epiblast stem cells 
In vitro, epiblast stem cell were initially derived from post-implantation epiblasts of rodents, 
in FGF2/Activin A supplemented medium. EpiSCs were shown to resemble more the 
pluripotent human ESCs (hESCs, see below) while showing patterns of gene expression and 
signaling responses that would normally function in the post-implantation epiblast (Tesar, et 
al., 2007). As opposed to ESCs, they are derived from the epiblast of the post-implantation 
embryo (E5.5-E7.5) (Joo, et al., 2014). In vitro they can be differentiated from ESCs by 
removing WNT and activating FGF and Activin signaling. If both WNT and FGF pathways are 
active, ESCs do not make the transition to EpiSCs, showing that WNT maintains naïve 
pluripotency regardless of FGF signaling. The two pluripotent stem cell types are easily 
distinguishable by their morphology, since EpiSCs form flat, irregular colonies and individual 
cells are easily identifiable. Furthermore, the maintenance and expansion of EpiSCs is done by 
breaking the colonies into clumps of cells and not a single cell suspension, from which they 
hardly recover because of interrupted cadherin signaling (Felicia Basilicata, Frank, Solter, 
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Brabletz, & Stemmler, 2016). Although pluripotent, as assessed by teratoma assays and to a 
lesser, much more inefficient way than ESCs, by chimera formation (Ohtsuka, Nishikawa-
Torikai, & Niwa, 2012), there are striking differences between ESCs and EpiSCs in terms of the 
marker genes they express and their gene expression profiles. A lower but still detectable 
expression of the core pluripotency transcription factors (Nanog, Oct4, Sox2) is 
complemented by the upregulation of lineage commitment factors such as Oct6 and Otx2, 
which also act as markers (Buecker, et al., 2014). In contrast to ESCs, this is the stage where 
de novo DNA methyltransferases (Dnmt3 members) are expressed and epigenetic marks 
established, which will “prime” the cells in development by allowing lineage commitment and 
establishment of a somatic epigenome (Brons, et al., 2007). For example, naïve marker genes 
like Stella and Rex1 are silenced by methylation upon the transition to EpiSCs (Bao, et al., 
2009). One of the most important epigenetic events occurring at this stage is the random 
inactivation of one of the X chromosomes in female cells (Guo, et al., 2009). In terms of their 
culture requirements, EpiSCs thrive in defined, serum-free medium supplemented with FGF 
and Activin (Brons, et al., 2007) (ten Berge, et al., 2011).  
The first hESCs derived from blastocysts showed significant differences with mouse ESCs in 
their characteristics and culture requirements (Thomson, et al., 1998). hESCs, either derived 
from blastocysts, or iPSCs obtained by direct in vitro reprogramming rely on FGF2 and Activin 
A, but not LIF signaling (Bertero, et al., 2015). Moreover, human ESCs do not upregulate the 
expression of FGF5 or N-CADHERIN mRNAs, and they have high levels of several naïve 
pluripotency marker genes (NANOG, PRDM14) (Gafni, et al., 2013). Other naïve pluripotency 
marker genes (e.g. REX1, KLF17, DPPA3) show a low expression in hESCs, similar to mouse 
EpiSCs (Chia, et al., 2010). The active deposition of H3K27me3 over developmental genes, loss 
of pluripotency upon inhibition of MEK-ERK signaling, lack of global hypomethylation (as seen 
in the ICM), and lack of a pre-X inactivation state in most conventional female human 
pluripotent lines suggest that hESCs are developmentally closer to murine EpiSCs (Smith Z. , 
et al., 2014) (Mekhoubad, et al., 2012). A complete parallel between hESCs and murine 
epiblast stem cells (EpiSC) cannot be drawn. hESCs are functionally dependent on NANOG and 
PRDM14, as losing these factors induces differentiation (Chia, et al., 2010). Even the 
distribution of DNA methylation is similar to murine ESCs grown in serum-supplemented 
medium, rather than murine EpiSCs expanded in FGF2/Activin A (Hackett, et al., 2013) 
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(Shipony, et al., 2014). Lastly, the localization of TFE3, whose intracellular redistribution 
affects the exit from pluripotency (nuclear TFE3 – no differentiation; cytoplasmic TFE3 – exit 
from pluripotency), is different from both murine pluripotent states: whereas in murine ESCs, 
TFE3 is located exclusively in the nucleus and in EpiSCs exclusively in the cytoplasm 
(Betschinger, et al., 2013), hESCs show an intermediate configuration, in which TFE3 is present 
in both the cytoplasm and nucleus (Gafni, et al., 2013). 
While we commonly tend to think of ESCs and EpiSCs as two completely separate cell types, 
the in vitro reality is that these two states are on opposite sides of a pluripotency spectrum. 
Each cell in culture has the ability to move closer or further away from naïve pluripotency, in 
the case of ESCs, or primed pluripotency, in the case of EpiSCs (Hayashi, Lopes, Tang, & Surani 
, 2008). This translates to some of the ESCs triggering differentiation to EpiSCs, as assayed for 
example by subtle changes in the expression of some genes. Depending on WNT activity, this 
transition can be completed or not. Vice-versa, EpiSCs do not normally revert to a “naïve” 
state, indicating a ‘point of no return’ in differentiation. The fully defined serum-free media 
supplemented with specific molecules helps keeping the naïve-primed 
differentiation/reversion processes in check and maintaining homogenous cultures. Whereas 
naïve pluripotency is maintained by LIF and WNT and primed pluripotency by FGF and Activin, 
exit from pluripotency is guided by an interplay between WNT, BMP and Nodal.  
5. Signaling pathways affecting pluripotency 
a. LIF signaling 
The ability to maintain and propagate naïve pluripotency in vitro through ESCs relies on two 
essential signaling pathways. Chronologically, the first identified was the Leukemia inhibitory 
factor (LIF) (Smith, et al., 1988) (Williams, et al., 1988). LIF is a member of the family of 
interleukin (IL)-6-type cytokines, which signal through a heterodimer consisting of the 
receptor subunit gp130, in association with the low-affinity LIF receptor (LIFR), a ligand-
specific receptor subunit (Graf, Casanova, & Cinelli, 2011). This complex leads to the activation 
of the receptor-associated Janus kinases (JAKs), which in turn phosphorylates receptor 
docking sites, and recruits the Src homology-2 (SH2) domain containing proteins such as STAT3 
(signal transducer and activator of transcription 3). Upon binding to the receptor, STAT3 
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molecules dimerize. The 
dimers then translocate to 
the nucleus, where they 
bind to promoters and 
enhancer regions of their 
target genes (figure 3). In 
mouse ESCs, LIF does not 
only activate the STAT3-
mediated cascade, but may 
also induce the ERK-
pathway, through the 
mitogen-activated protein kinase (MAPK) (Shoni, et al., 2014).  
LIF signaling was shown to be necessary to maintain self-renewal of mouse ESCs in the absence 
of feeders (Matsuda, et al., 1999) (Niwa, Burdon, Chambers, & Smith, 1998) (Cinelli, et al., 
2008). Among its downstream targets, the transcription factor c-MYC was described to have 
a significant role in self-renewal by functioning as a key target of LIF/STAT3 signaling 
(Cartwright, et al., 2005). In support of this hypothesis, constitutive expression of c-Myc was 
shown to support self-renewal independent of LIF activity. This observation was made for 
other genes involved in the maintenance of pluripotency, such as Nanog (Chambers, et al., 
2003) or Klf2 (Hall, et al., 2009). Expression of a dominant negative form of c-MYC promotes 
differentiation (Cartwright, et al., 2005). 55% of the putative STAT3 target genes display 
binding sites for NANOG, and 41% of the putative NANOG target genes display binding sites 
for STAT3 (Chen, et al., 2008). LIF/STAT3 was also shown to target Klf4 (Hall, et al., 2009) (Niwa, 
Ogawa, Shimosato, & Adachi, 2009). This emphasizes the co-regulation of the expression of a 
large set of target genes by these transcription factors, which are involved in the maintenance 
of naïve pluripotency.  
b. WNT signaling 
The WNT signaling pathways are a group of highly conserved signal transduction pathways 
formed by proteins that carry signals from outside of a cell through cell surface receptors to 
the inside of the cell. In vivo, WNT activity was detected in E3.5 and E4.5 mouse embryos, but 
 
Figure 3. Schematic representation of the LIF-pathway. 
GAB1
gp130 LIFR
Jak Jak
P P
SOCS3
STAT3
P
STAT3
P
STAT3
P
Self-renewalDifferentiation
ERK
MAPK
MEK
Raf
SHP2
PIP3K
SOS
GRB2
Ras
GDP
GTP
CHAPTER 1 
20 
not in E5.5 implanted embryos (ten Berge, et al., 2011). WNT activity can once again be 
detected in the region of the primitive streak, starting from E6.5 (ten Berge, et al., 2008). 
There are three pathways 
that have been described: 
(i) the canonical WNT 
pathway, which leads to 
the regulation of gene 
expression, (ii) the 
noncanonical planar cell 
polarity pathway, which is 
responsible for the shape of 
the cytoskeleton and (iii) 
the noncanonical 
WNT/calcium pathway, which regulates the intake of calcium (Komiya & Habas, 2008). First 
described in Drosophila as the Wingless gene (Wg), and in mouse as the int1 (integration 1) 
oncogene, they were later discovered to be part of the same pathway which was renamed 
WNT (Wingless-related integration site) (Rijsewijk, et al., 1987) (Nusse, et al., 1991). Of 
relevance for pluripotency is the canonical WNT pathway (Wray, et al., 2011) (ten Berge, et 
al., 2011). The family is comprised of 19 WNT signaling proteins in human and mouse. Given 
the correct signals, a cell will start transcribing Wnt genes, which will be translated in the 
cytoplasm into 350-400 amino acid proteins. The proteins are post-translationally lipid-
modified by palmitoylation, which is required for the initiation of the targeting of the WNT 
protein to the plasma membrane, followed by its secretion. The protein is also glycosylated to 
insure proper secretion (Kurayoshi, Yamamoto, Izumi, & Kikuchi, 2007). In vitro, WNT 
production can be blocked by using a synthetic molecule called Inhibitor of WNT Production 
2 (IWP2) which inhibits the enzyme that palmytoylates WNT, porcupine (Chen, et al., 2009). 
After secretion, the WNT protein mostly acts in an autocrine or paracrine manner. In the 
canonical pathway, upon binding to its receptors, Frizzled and its co-receptor LRP5/6, the WNT 
signal reaches the phosphoprotein Dishevelled which in turn sequesters the “destruction 
complex” to the cell membrane (Rao & Kuhl, 2010) (Komiya & Habas, 2008) (figure 4). This 
complex is made of Axin, adenomatosis polyposis coli (APC), glycogen synthase kinase 3 
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(GSK3) and casein kinase 1α (CK1α) (Minde, Anvarian, Rudiger, & Maurice, 2011). In the 
absence of WNT signaling, the “destruction complex” degrades β-catenin by targeting it for 
ubiquitination and proteasomal digestion (MacDonald, Tamai, & He, 2009). Immediately upon 
binding of a WNT protein to its receptors, the “destruction complex” is disturbed, which leads 
to an accumulation of β-catenin in the cytoplasm followed by its translocation to the nucleus. 
Here, it acts as a transcriptional coactivator of transcription factors belonging to the TCF/LEF 
family. In vitro, instead of soluble WNT proteins, the pathway can also be activated by the 
addition of a GSK3 inhibitor, as is the case in the 2i culture condition of ESCs. While TCF1, TCF4 
and LEF1 are not bound to DNA when WNT is off and activate genes once beta-catenin 
translocates to the nucleus, TCF7L1 is bound to DNA even in the absence of WNT (without 
GSK3 inhibitor) and has a repressive role (Staal & Clevers, 2000) (Yi, et al., 2011). Upon WNT 
activation, this repression is relieved and active transcription begins (Wu, et al., 2012). 
Moreover, TCFf3 has been shown to act broadly, genome-wide, to reduce the levels of naïve 
genetic markers (Nanog, Tbx3, Esrrb) while not affecting genes that show a relatively similar 
expression in both ESCs and EpiSCs (Oct4, Sox2, Fgf4). This has led to the conclusion that 
TCF7L1 acts as an inhibitor of naïve pluripotency cell self-renewal (Yi, Pereira, & Merrill, 2008). 
Contradicting reports indicated that β-catenin may not be needed for transcription, but for 
cadherin-mediated cell adhesion (Lyashenko, et al., 2011). Other hypothesis implies that beta-
catenin directly interacts with the pluripotency network by upregulating Nanog after 
physically associating with OCT4 (Takao, Yokota, & Koide, 2007) (Kelly, et al., 2011). In 
contrast, WNT signaling has a different function in primed pluripotency. Instead of stimulating 
self-renewal, WNT signaling effectively stimulated differentiation of EpiSCs.  
Several earlier studies of the role WNT has in ES cells suggested that the signal triggers 
differentiation. Otero et al. observed neural differentiation in ESCs cultured with WNT3a 
conditioned medium (Otero, Fu, Kan, Cuadra, & Kessler, 2004). Overexpression of β-catenin 
yielded similar results. Not all reports, upon induction of WNT signaling, show differentiation 
or commitment towards the same lineage. Others reported that WNT signaling is required for 
mesoderm/endoderm specific differentiation in both human and mouse ES cells (Bakre, et al., 
2007) (Lindsley, Gill, Kyba, Murphy, & Murphy , 2006). Activation of WNT signaling either by 
supplying cells with WNT3a or by inhibiting GSK3 resulted in the upregulation of certain 
mesoderm and endoderm specific markers in human and mouse ES cells. The progenitor cells 
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could still be maintained long term in culture despite the partial differentiation, suggesting 
that WNT signaling might be responsible for the self-renewal of these cells. Other studies 
showed that overexpression of stabilized β-catenin led to an increase in self-renewal and 
impaired neural differentiation in mouse cells after 14 days of embryonic body formation. 
Together, these studies suggest an important role for WNT signaling during early 
differentiation. All these results are in sharp contrast with other studies in which WNT3a 
(either purified protein or conditioned medium) did not induce differentiation but was instead 
reported to promote self-renewal of ESCs (ten Berge, et al., 2011) (Sato, Meijer, Skaltsounis, 
Greengard, & Brivanlou, 2004). In contrast, Davidson et al. found that activation of WNT 
signaling either by supplying hESCs with WNT3a or by inhibiting GSK3 reduced self-renewal, 
indicating a significantly different role for WNT in hESCs (Davidson, et al., 2012). The 
requirement of WNT signaling during differentiation does not exclude that WNT signaling is 
also paramount for ESC self-renewal. 
c. FGF signaling 
In 1974, a protein was identified that, upon tests in bioassays, was discovered to promote 
fibroblast proliferation (Gospodarowicz, 1974). It was later found that this protein belonged 
to a bigger family of proteins, fibroblast growth factors (FGF). FGFs are proteins that interact 
with membrane-associated heparan sulfate proteoglycans, in the form of four receptors 
(FGFR1, FGFR2, FGFR3 and FGFR4), driving FGF signal transduction and thus constituting the 
FGF signaling pathway. It is involved in several important processes, like angiogenesis, wound 
healing, proliferation, survival, migration and differentiation. Of relevance for this thesis is the 
role FGF signaling has in the early embryonic development in vivo and the loss of naïve 
pluripotency/gain of primed pluripotency.  
After binding to its receptors, the FGF signal can be carried through four distinct pathways: 
the Janus kinase/signal transducer and activator of transcription (JAK/STAT), phosphoinositide 
phospholipase C (PLC), phosphatidylinositol 3-kinase (PI3K) and MAP kinase pathways (Dailey, 
Ambrosetti, Mansukhani, & Basilico, 2005). MAP kinases are a family of proteins that control 
the activity of downstream kinases and transcription factors. In pluripotent stem cells MAP 
kinase is active through MEK1 and MEK2, which in turn regulate the transcriptional activity of 
ERK1/2. Early in development (E3.0-E3.75) FGF regulates the formation of primitive endoderm 
from the ICM (no connection to the naïve-primed transition). Later in development (not clear 
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when this happens in vivo but peri-implantation), FGF is required for the transition to primed 
pluripotency. Upon activation of ERK1/2 by FGF stimulation, it was demonstrated that 
pluripotent ESCs lose the ability to self-renew and gain the capacity to undergo lineage 
commitment (Kunath, et al., 2007). While ESCs experience autocrine FGF4 signaling (Ma, et 
al., 1992), only after removal of WNT activity do the cells undergo the transition (ten Berge, 
et al., 2011). This indicates WNT and FGF have sequential roles in the naïve-primed transition. 
Since then, it was shown that ERK activation leads to the export of KLF4 from the nucleus of 
ESCs, which in turn leads to a rapid decline in Nanog and Klf4 transcription. This disrupts the 
entire core pluripotency network, leading to differentiation (Dhaliwal, Miri, Davidson, Tamim 
El Jarkass, & Mitchell, 2018).  
The report by ten Berge et al. in 2011 showed that using the same MEK inhibitor as in the 2i 
ESC culture condition, together with soluble WNT protein, lowers the level of WNT3a protein 
required for optimal self-renewal (ten Berge, et al., 2011). The existence of an interaction 
between the two pathways and at what level is still an open question in the field (Kurek & ten 
Berge, 2012). Consistent with the in vitro data, FGF4 was also detected in the inner cell mass 
of the blastocyst (Rappolee, Basilico, Patel, & Werb, 1994). WNT activity has been detected in 
vivo at E3.5 and E4.5, but not at E5.5, stages which developmentally correspond to naïve and 
primed pluripotent states, respectively (ten Berge, et al., 2011), suggesting that WNT activity 
must be inhibited for the transition from one state to another to occur. Additionally, 
suppression of ERK signaling stimulates the maintenance of naïve cells within the ICM in the 
mouse embryo by blocking specification of primitive endoderm (Nichols, Silva, Roode, & 
Smith, 2009). 
d. Nodal/Activin signaling 
The primitive streak formation is initiated by WNT and Nodal, on the posterior side of the 
embryo (Huelsken, et al., 2000) (Brennan, et al., 2001), while primitive streak formation is 
inhibited at the future anterior side of the embryo by growth factor antagonists and 
intracellular back-up mechanisms (Pereira, et al., 2012). A positive feedback loop is initiated 
where proNodal (Nodal precursor) induces the expression of Bmp in the extraembryonic 
ectoderm (Ben-Haim, et al., 2006). BMP then promotes the expression of Wnt3 in the 
posterior epiblast, the site of the primitive streak. WNT signaling induces the T box 
transcription factor Brachyury, routinely used as a mesodermal marker, which has an 
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important role in the establishment of the anterior-posterior axis. WNT activity also positively 
regulates the levels of proNodal, which initiates the feedback loop. 
Nodal belongs to the transformation growth factor beta (TGFβ) superfamily of secreted 
growth factors. Nodal (and Activin A, which mimics its effects) activates a complex of type I 
and type II cell surface serine threonine kinase receptors, that in turn phosphorylate the 
downstream cytoplasmic effector proteins SMAD2 and SMAD3. Phospho-SMAD complexes 
(usually 2/3), in association with the co-SMAD, SMAD4, translocate to the nucleus and, acting 
together with additional DNA-binding partners, selectively regulate target gene expression 
(figure 5) (Massague, Seoane, & Wotton, 2005). In the mouse embryo, Nodal activity peaks in 
the anterior primitive streak (Kaufman-Francis, et al., 2014). In vitro, mouse EpiSCs are 
maintained by culturing them in the presence of Activin A (another TGFβ-related factor) and 
FGF2, reminiscent of the provision of Nodal and FGF signals at the anterior primitive streak 
(Tam & Loebel, 2007). Similarly, TGFβ signaling through Activin/Nodal is necessary for the 
maintenance of pluripotency in human embryonic stem cells (James, Levine, Besser, & 
Hemmati-Brivanlou, 2005).  
e. BMP4 signaling 
BMPs are also members of the TGFβ superfamily. They are involved in regulation of cell 
proliferation, differentiation, and apoptosis, and therefore play essential roles during 
embryonic development and pattern formation (Massague, TGF-beta signal transduction, 
1998). BMP functions through receptor-mediated intracellular signaling and subsequently 
influences target gene transcription, similar to Nodal. Two types of receptors are required in 
this process, type I and type II. While there is only one type II BMP receptor (BMPRII), there 
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are three type I receptors: ALK2, ALK3 
(BMPR1A) and ALK6 (BMPR1B). Different 
combinations of type II with any one of the 
type I receptors may determine the 
specificity and result in different 
consequences. There are two well-defined 
signaling pathways involved in BMP signal 
transduction (Derynck & Zhang, 2003). The 
canonical BMP pathway is through 
receptor I mediated phosphorylation of 
SMAD1, SMAD5 or SMAD9 (previously 
known as SMAD8) (figure 6). Two 
phosphorylated SMADs form a 
heterotrimeric complex with a common 
SMAD4. The SMAD heterotrimeric complex translocates into the nucleus and cooperates with 
other transcription factors to modulate target gene expression. A parallel pathway for the 
BMP signal is mediated by TGFβ1 activated tyrosine kinase 1 (TAK1, a MAPKKK) and through 
mitogen activated protein kinase (MAPK) (Derynck & Zhang, 2003) (Massague, 2000), which 
also involves cross-talk between the BMP and WNT pathways (Smit, et al., 2004) (Ishitani, et 
al., 2003). In Xenopus, dorsal-ventral polarity patterning was shown to be an effect of dorso-
ventral BMP and antero-posterior WNT signaling, through inhibition of phospho-BMP-SMADs 
by concerted action of GSK3β and MAPK (Fuentealba, et al., 2007).  
BMP4 was shown to induce the differentiation of primed pluripotent cells (Ying, Nichols, 
Chambers, & Smith, 2003). In contrast, LIF through STAT3 can block mesoderm and endoderm 
differentiation but favors neural differentiation (Ying, Nichols, Chambers, & Smith, 2003). 
BMP4 drives hESC differentiation into a mixture of mesoderm and trophoblast committed 
cells (Drukker, et al., 2012). In addition, supplementing the culture of hESCs with BMP4 
induces a rapid decrease in the level of expression of OCT4 and SSEA3, while increasing the 
expression of the differentiation gene marker SSEA1 (Vallier, et al., 2009). This confirms that 
in contrast to mouse ESCs, hESCs are not maintained as pluripotent cells by BMP4 signaling.  
 
Figure 6. Schematic representation of the BMP 
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6. Epigenetic seesaw 
As important as signaling pathway effectors and transcription factors are, an additional layer 
of complexity is laid by the epigenetic machinery. Epigenetic modifications and cofactors play 
a significant role both in the maintenance of the two pluripotent states, but also in their 
transition. Transcriptional co-activators and co-repressors are protein complexes that do not 
bind DNA on their own, but regulate the action of sequence-specific transcription factors via 
chromatin-mediated mechanisms (Li & Belmonte, 2017). 
Histone modifications have been extensively used to define and annotate distinct functional 
regions such as promoters and enhancers. The chromatin landscape of pluripotent cells was 
first described in murine ESCs. It showed that active and repressive chromatin marks colocalize 
genome-wide, for instance the trimethylation of lysine 4 on histone 3 (H3K4me3) and 
trimethylation of lysine 27 on histone 3 (H3K27me3) (Bernstein, et al., 2006) (Azuara, et al., 
2006). This ‘bivalent’ chromatin signature is considered a key element that enables genes 
repressed in ESCs to follow alternative fates. In hESCs, a significant set of genes shows the 
same bivalent H3K4me3 and H3K27me3 marking, but few genes exhibit H3K27me3 alone 
(Pan, et al., 2007) (Zhao, et al., 2007). This indicates that, at least in hESCs, bivalency is the 
default chromatin state at genes essential for proper developmental control. A particular 
feature associated with the naïve phase of pluripotency is the presence of two active X 
chromosomes in female cells. In XX embryos the paternal X is initially inactive (Takagi & Sasaki, 
1975) and is reactivated in the naïve epiblast (Mak, et al., 2004). Subsequently, one of the X 
chromosomes is randomly inactivated in each cell. In common with the naïve epiblast, female 
ESCs exhibit two active X chromosomes that undergo random inactivation during 
differentiation (Rastan & Robertson, 1985). 
ESCs are extremely sensitive to oscillations in several cofactors, such as Mediator and cohesin 
(Kagey, et al., 2010), the Tat-interactive protein – p400 chromatin remodelling complex 
(Fazzio, Huff, & Panning, 2008), the RNA polymerase-associated factor 1 (PAF1) complex (Ding, 
et al., 2015), and the co-repressors CCR4-NOT transcription complex subunit 3 (CNOT3) and 
tripartite motif-containing protein 28 (TRIM28) (Hu, et al., 2009). Mediator and cohesin are 
especially relevant for the maintenance of naïve pluripotency, due to their role in the 3D 
genome organization of the core pluripotency transcription machinery. Mediator and cohesin 
are relatively large protein complexes that enable physical interaction between transcription 
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factor-bound enhancers and promoters (Li, Liu, & Izpisua Belmonte, 2012) (Gorkin, Leung, & 
Ren, 2014). The transcription of pluripotency-associated genes depends on interactions 
between distant regulatory elements. For instance, the expression of Oct4 requires its 
upstream enhancer, bound by OCT4, SOX2, KLF4, Mediator and cohesin, to come into contact 
with its promoter (Wei, et al., 2013) (Zhang, et al., 2013). 
EpiSCs show several differences, when compared to ESCs, in enhancer histone modifications. 
For example, Oct4 enhancer usage switches from a distal enhancer (DE, preferentially used in 
the naïve state) to a proximal enhancer (PE, primarily used in the primed state) (Tesar, et al., 
2007) (Yeom, et al., 1996). DNA methylation also varies: whereas ESCs have hypomethylated 
genomic DNA, EpiSCs are hypermethylated (Weinberger, Ayyash, Novershtern, & Hanna, 
2016) (Hackett, et al., 2013) (Hayashi, Lopes, Tang, & Surani , 2008). Perhaps the difference 
easiest to observe in the status of the X-chromosome inactivation in female cells. Whereas 
female ESCs have both X chromosomes active, in EpiSCs the random inactivation of one of 
them is already completed (Guo, et al., 2009) (Bao, et al., 2009). 
Thus, the transition from naïve (ESCs) to primed (EpiSCs) pluripotency is induces significant 
changes in the chromatin landscape. It then becomes essential for naïve cells to undergo an 
intermediary state, where they remove naïve marks and lay primed ones, as it allows proper 
remodeling in order to prepare for the correct segregation of all definitive embryonic lineages. 
The exact steps and sequence of events in the naïve-to-primed remodeling, as well as their 
function, are currently poorly understood. Learning more about this process could provide 
insight into how to direct it in the reverse way (i.e. reprogramming), to increase its efficiency.  
7. Reprogramming somatic cells to pluripotent stem cells  
In 2006, the direct in vitro reprogramming of somatic cells to pluripotency by ectopic 
expression of defined factors was achieved in groundbreaking research by Yamanaka, with the 
final aim of using these “induced pluripotent stem cells” for gene therapy (Takahashi K. & 
Yamanaka S., 2006). In theory, one could harvest cells (e.g., fibroblasts) from a diseased 
patient, reprogram them to a pluripotent stem cell state which can expand indefinitely, use 
gene editing technologies to fix the underlying defect (with, for example, CRISPR/Cas9), 
differentiate the stem cells back to cell types of interest and perform an autologous transplant 
back into the patient, thus curing the disease. Viewed as a “Holy Grail” in modern medicine, 
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this approach to personalized medicine is sidestepping the ethical issues of working with 
human embryonic stem cells but it is still hindered by a number of factors, mainly inefficient 
reprogramming/differentiating, especially in the human cells, of most clinical importance. 
That is due to a failure to erase their epigenetic memory; instead they acquire a state that 
resembles developmentally-primed cells, with a differentiation potential biased towards their 
lineage of origin (Kim, et al., 2010). In contrast, mouse iPSCs acquire a state of naïve 
pluripotency that supports complete reprogramming. Ultimately, it is the growth conditions 
that are used to expand such cells in vitro that determine the pluripotent state they attain (i.e. 
complete erasure of developmental history or developmentally-primed) (Hanna, et al., 2009). 
The key to unlock the full potential of human iPSCs rests therefore in understanding the 
essential differences between the different types of pluripotency. 
8. Scope of the thesis 
The focus of this thesis is on extending our knowledge on stem cell biology by investigating 
different aspects of pluripotency in mouse and human pluripotent stem cells. Specifically, we 
aimed to thoroughly describe the effect key signaling pathways have on pluripotency, with a 
particular view towards providing a more complete view of the controversy of the role of WNT 
signaling in pluripotency. This thesis aimed to investigate the major differences between naïve 
and primed pluripotent cells derived from both mouse and human, the balance between 
various signaling pathways that lead to pluripotency maintenance or exit, and how their 
downstream effectors lead to different pluripotency states. 
Chapter 2 investigates EpiSCs and the cues these cells respond to. Specifically, we aimed to 
describe the effect of WNT signaling on primed pluripotency. In vivo, the corresponding cells 
see a pulse of BMP and WNT during gastrulation. We proceeded with describing this process 
in vitro. We found that BMP induces Wnt. Consequently, the activation of WNT pathway leads 
to loss of pluripotency in EpiSCs and hESCs. Moreover, in EpiSCs, WNT inhibition confines the 
cells to a pregastrula epiblast state which is able to contribute to blastocyst chimeras. Our 
findings led to a clear model of how WNT affects exit from pluripotency, ending the 
controversy around the contradicting findings previously published which indicated that WNT 
can both maintain naïve pluripotency but also trigger differentiation. This chapter also 
describes new culture conditions that maintain homogenous cultures of mouse EpiSCs and 
human ESCs. 
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Chapter 3 addresses the question of identifying the specific roles WNT and MEK inhibition 
have in naïve pluripotency, in the mouse early embryo, as they are not needed simultaneously 
for a homogenous culture. In doing so, we identified a novel pluripotent stem cell type, which 
shares characteristics with both ESCs and EpiSCs, while also having unique features. 
Interestingly, cells with similar properties are found in the peri-implantation embryo, shortly 
after the cells gain polarity and form the embryonic rosette, indicating that they occupy an 
intermediate pluripotent state. This chapter focuses on the characterization of this newly 
identified stem cell type, which we named Rosette-like stem cells. The identification and in 
vitro capture of rosette-stage pluripotency allows new insights into the processes that install 
functional pluripotency. 
Chapter 4 is based on the findings from Chapter 2, that WNT signals regulate the transition 
from naïve pluripotency to rosette-stage pluripotency. Our focus in this chapter was to obtain 
mechanistic insight into the regulation of this pluripotent state transition by WNT signals. 
Therefore, we set out to identify and characterize the transcription factor complexes that 
mediate the effects of WNT signals in these states. 
Chapter 5 presents an exploratory study that identifies downstream targets of the 
pluripotency signaling pathways regulating the naïve-rosette transition. We identify possible 
synergies in targets between signaling pathways which may highlight key players in the 
transition. Moreover, we found a specific link between the MEK signaling pathway and the 
DNA hypomethylation observed in naïve pluripotency in vitro. 
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General discussion and future direction 
 Pluripotency is an innate and, to a certain extent, flexible potential of cells to generate 
all embryonic lineages. This comprises mesoderm, definitive endoderm and ectoderm 
derivatives, along with germ cells. In the embryos of eutherian mammals, pluripotency first 
appears within the inner cell mass (ICM). Here, the first pluripotent tissue is the epiblast of 
the developing embryo. In preparation for deploying the adult organism blueprint, over a 
period of several days (in mouse) or approximately two weeks in human embryos, these cells 
undergo significant cellular, transcriptional and epigenomic changes. Pluripotency is often 
referred to as naïve or primed, two states that correspond to the pre- and post-implantation 
pluripotent populations in the embryo, and their in vitro counterpart stem cells: embryonic 
stem cells (ESCs) and epiblast stem cells (EpiSCs). Mouse ESCs (and the mouse pre-
implantation epiblast) are characterized by the production of OCT4, SOX2, KLF4, TFCP2L1, 
ESRRB, TBX3 and NANOG, which are absent from the EpiSCs (and the post-implantation 
epiblast). These transcription factors form a “core pluripotency network” that controls and 
sustains naïve pluripotency. Upon differentiation of ESCs to EpiSCs, as the naïve factors are 
negatively regulated, the expressions of Otx2 and Oct6 increase. This triggers the 
differentiation of ESCs, i.e. loss of naïve pluripotency, and mirrors the transcriptional changes 
that occur in the late blastocyst. There, in an identical pattern, Nanog expression is repressed 
before implantation, concurrent with the increase in expression of Otx2 and Oct6. Among the 
other factors that are differentially expressed between the two cell types, the de novo 
methyltransferases Dnmt3a and Dnmt3b are induced, which, both in vivo and in vitro, leads 
to a significant genome-wide increase in CpG methylation.  
The transition from one state to the other (or its inhibition) is tightly regulated by several 
signaling pathways: LIF and WNT (for ESCs – naïve pluripotency) and FGF through MEK 
signaling and Activin (for EpiSCs – primed pluripotency). Despite knowing what factors are 
required for the maintenance of naïve pluripotency or the differentiation to primed 
pluripotency, it is still unclear what molecular mechanisms these signaling pathways trigger 
and whether they act in synergy. Our goal was to investigate the molecular cascades 
regulating the transition between different pluripotency states and their biological relevance. 
Clarifying these transitions can have a significant impact on improving reprogramming 
protocols and understanding how lineage decisions are affected and implemented. 
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Key thesis insights 
Chapter 2 ▪ BMP induced differentiation in mouse EpiSCs is mediated by WNT signals; 
▪ Endogenous WNT proteins induce differentiation and loss of pluripotency 
in EpiSCs; 
▪ WNT inhibition maintains EpiSCs in a pregastrula epiblast stage; 
▪ EpiSCs can contribute to blastocyst chimeras if their transcriptional profile 
corresponds to pregastrula epiblast; 
▪ Inhibition of endogenous WNT signals prevents the accumulation of 
differentiated cells in human ESC cultures. 
Chapter 3 ▪ WNT signals block lumenogenesis and progression to a rosette-like state, 
while MEK inhibition does not affect this transition but blocks subsequent 
pluripotency progression to the primed state; 
▪ MEK/WNT-inhibited cells display rosette-like features; 
▪ MEK/WNT-inhibited cells display bivalent marking of primed genes; 
▪ MEK/WNT-inhibited cells acquire rosette-specific formatting of pericentric 
heterochromatin; 
▪ OTX2 regulates entry into the rosette-like state; 
▪ MEK/WNT-inhibited cells represent a novel type of pluripotent cells, 
termed rosette stem cells (RSCs). 
Chapter 4 ▪ TCF7L1-/- ES cells inefficiently differentiate to RSCs; 
▪ WNT activity induces significant changes in the binding pattern of TCF7L1 
to protein complexes; 
▪ Whereas the core pluripotency network in ESCs contains OCT4, SOX2, 
NANOG, KLF4 and TCF7L1, the one in RSCs only contains OCT4, SOX2 and 
TCF7L1, which may explain the faster differentiation of the RSCs to EpiSCs; 
▪ WNT may direct Polycomb-mediated repression to genes involved in the 
transition to the primed state; 
Chapter 5 ▪ Otx2 is among the first responders to reduced LIF and WNT activity, 
emphasizing its key role in coordinating the transition from naïve to primed 
pluripotency; 
▪ DNA demethylation is not a key feature of ESCs, but rather a ‘side-effect’ 
of culture due to MEK inhibition; 
▪ The cell motility observed in RSCs is repressed by MEK and supported by 
MEK inhibition. 
In Chapter 2 we focused on investigating the effects of endogenous WNT signals on 
the differentiation and self-renewal of both human and mouse pluripotent cells. This work 
pinpoints endogenous WNT signals as mediators of differentiation decisions in response to 
BMP signaling, and demonstrate that these endogenous signals are the main cause of 
spontaneous differentiation in both human ESCs and mouse EpiSCs. In addition, we 
demonstrate that BMP4 induces two differentiation pathways, one WNT-dependent to 
primitive streak and one WNT-independent to trophoblast. We showed that endogenous WNT 
signals induce differentiation and loss of pluripotency in EpiSCs, leading to a new culture 
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condition that maintains homogenous EpiSC populations: serum free medium (N2B27) 
supplemented with FGF, Activin and IWP2 (inhibitor of WNT production 2). Our data shows 
that EpiSCs cultured without WNT signals more closely resemble the pre-gastrula stage of 
embryonic development, highlighted by the ability of these cells to contribute to chimeras 
upon blastocyst injections. Endogenous WNT signals push the EpiSCs to a phenotype 
resembling the late-gastrula stage epiblast, consisting of a mixture of EpiSCs in various stages 
of differentiation. In addition, we also showed that the inhibition of endogenous WNT signals 
prevents the accumulation of differentiated cells in human ESC cultures. An exciting recent 
development is the generation of synthetic embryos from ESCs and trophoblast stem cells 
(TSCs) (Rivron, et al., 2018). This allows the investigation of interactions between the different 
tissue types of the blastocyst and their roles in regulating development. Human TSCs have not 
been established yet, but if we can efficiently generate human trophoblast cells by using 
defined media as published in this chapter, we might be able to generate human trophoblast 
cells to create human synthetic embryos to address such questions. 
In Chapter 3, we demonstrated that WNT and MEK signals act subsequently to arrest 
different states of pluripotency. Our work led to the description of a novel, third pluripotent 
state, which we termed 
rosette-like, after the in vivo 
equivalent of cells with similar 
characteristics. Whereas ESCs 
are reliant on LIF and WNT for 
their maintenance, and EpiSCs 
rely on the removal of WNT 
factors and activation of MEK, a 
novel pluripotency state can be 
stably maintained in culture 
through a combination of both 
WNT and MEK inhibition, in the 
presence of LIF (Figure 1). We showed that rosette-like stem cells (RSCs) share some 
characteristics with ESCs, such as the expression of a subset of genes considered specific for 
naïve pluripotency. These properties are relevant for a long-standing debate with regards to 
 
Figure 1. Schematic representation of the three pluripotent states 
and their signaling requirements, as defined in the mouse model 
Lif
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naïve pluripotency and its WNT requirement. Some groups have previously argued that WNT 
signals are not required for ESC maintenance, as some cells cultured in the absence of WNT 
are still able to generate chimeras and show a panel of naïve markers (Augustin, et al., 2017) 
(Biechele, Cockburn, Lanner, Cox, & Rossant, 2013). Chapter 3 demonstrates that this is not 
the case, and indicates that most likely, these groups were culturing RSCs. A still open question 
is on the status of ESCs cultured in LIF+serum. Although these cultures are still pluripotent, as 
demonstrated by their ability to generate high-contribution chimaeras with germline 
transmission, it is a well-established fact that ESCs maintained in serum are often 
morphologically heterogenous and also express pluripotency associated transcription factors 
in a heterogenous manner (Toyooka, Shimosato, Murakami, Takahashi, & Niwa, 2008) (Marks, 
et al., 2012). This mosaic transcription factor expression indicates that the ESCs cultured in 
serum are not only heterogenous ESCs, but cultures consisting of different cell types, including 
ESCs and RSCs, and perhaps EpiSCs due to the variability of serum composition.  
Chapter 3 also includes a comprehensive description of RSC-specific characteristics, 
such as co-production of KLF4 and OTX2, apicobasal polarity, cell motility and accumulation of 
H3K27me3 in the pericentric heterochromatin. These features are consistent with the 
transformations occurring in vivo when transitioning from the inner cell mass to the epiblast, 
through the embryonic rosette. An important finding was that WNT blocks Otx2 induction, 
lumenogenesis and the methylation of H3 at K27. Our data shows that the dynamic and global 
increase in DNA methylation that occurs as ESCs exit the naïve state and differentiate into 
RSCs creates a methylome intermediate between naïve and primed pluripotency. Our gene 
expression profiling indicates that the increased methylation in RSCs may be an artefact 
resulting from MEK inhibition, and not a driver/initiator of initial exit from naïve to rosette 
pluripotency, a hypothesis further investigated in Chapter 5. We observed the rosette 
pluripotent state as a naïve-primed intermediate both in vitro and in vivo, suggesting that it is 
a required intermediate. Our data lays the foundation of future studies that should provide 
an additional layer of insights into the molecular dynamics and drivers of transition through 
the three distinct stages of pluripotency. Equally important will be to verify whether the 
transition events we observe in our fully defined in vitro culture system are an accurate 
representation of the events occurring in vivo. In the embryo, the cells transition from naïve 
to primed pluripotency in a closely synchronized manner, whereas the in vitro differentiation 
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is more inconsistent, asynchronous and takes a longer time. Elucidation of the developmental 
program of transitions at a single-cell level is therefore fundamental in understanding how 
lineage decisions are set up and executed.  
In light of our identification of RSCs in mouse, it would be important to investigate the 
existence of a similar state in human cells. A key question remains, of whether RSC-like human 
cells can be derived by conversion of human ESCs. Given that human ESCs more closely 
resemble mouse EpiSC, and the latter do not efficiently revert to RSCs, we hypothesize that it 
may be challenging to derive hRSCs from hESCs, without first describing a state in human cells 
that resembles naïve pluripotency. Similarly, exploring whether the ESC-RSC-EpiSC transition 
in human cells is triggered by the same factors or in the same order might generate insights 
relevant to IVF or oncology. For instance, human IVF embryos often implant but then fail to 
develop further. Our work provides some insight into the processes that regulate further 
development, in mouse. This thesis hints at signaling-regulated embryonic checkpoints, 
involving the different tissue types of the blastocyst. 
In Chapter 4 we explored the role of TCF7L1 (also known as TCF3) in ESCs and RSCs, as 
despite the absence of WNT signaling, naïve genes are not repressed yet in the latter. This 
work focused on unravelling the molecular interactions that allow ESCs and RSCs to share 
naïve characteristics although they are maintained under opposite levels of WNT activity. First, 
we showed a direct correlation between TCF7L1 overexpression and a higher concentration 
of WNT required to counter-act its repressing effect, demonstrating that WNT relieves TCF7L1 
repression to maintain naïve characteristics. In contrast, cells lacking TCF7L1 significantly slow 
down the transition of ESCs to RSCs.  Additional work would be required to understand why 
the transition is not altogether stopped, and what other factors are involved in it.  
An important outcome of Chapter 4 is a map of TCF7L1 interactors in RSCs, both when 
WNT signaling was inactive (true RSCs) and active (RSCs cultured with WNT for 4 hours). Our 
data showed NuRD and SWI/SNF as complexes pulled down irrespective of WNT activity. 
Moreover, we observed a compositional change of the TCF7L1 interactome, from a complex 
containing OCT4, SOX2, NANOG, KLF4 and TCF7L1 (in presence of WNT), to one only 
containing OCT4, SOX2 and TCF7L1 (in absence of WNT), providing insight into the faster 
differentiation of RSCs to EpiSCs, which we demonstrated in Chapter 3. This suggests KLF4 and 
NANOG may bring TCF7L1 to genomic binding sites specific to naïve pluripotency. To fully 
CHAPTER 6 
212 
define the existence of one complex containing all the factors above would require different 
pulldowns for each factor. Several complexes pulled down predominantly in the sample where 
WNT signaling was active indicate that WNT target genes are silenced in RSCs but become 
active within 4 hours of WNT activity. An important follow-up to this work would be to enrich 
this data with ChIP-Seq experiments to determine whether the changes in the TCF7L1 complex 
indeed result in changes in genomic localization. We also pulled down several Polycomb group 
proteins in the RSC sample treated with WNT, indicating a previously unknown connection 
between the repressive Polycomb complex and ESCs/RSCs. Additional pulldowns combined 
with knockdowns would further validate this link.  
In addition to WNT signaling, MEK inhibition was also shown to support ESC self-
renewal in the absence of LIF, when combined with GSK3 inhibitor (which activates the WNT 
pathway) or WNT3a soluble protein, although at a severely compromised level (Kurek & ten 
Berge, 2012). The mechanism hypothesized for this relies on the inhibition of autocrine FGF4 
signals (Kunath, et al., 2007). As supporting evidence, it was shown that GSK3 inhibition is 
enough to support FGF4-/- ESCs (Ying, et al., 2008). In Chapter 5 we set out to confirm that 
ESC maintenance does not depend on MEK inhibition, and that this pathway is relevant for 
the maintenance of RSCs, through gene expression analysis. An important finding of this 
chapter is the early response of the Otx2 gene to withdrawal of either LIF or WNT. The gene’s 
upregulation is the highest when both factors are removed, consistent with the ESC-RSC-EpiSC 
transition and the effect of the signaling pathways on it. Previous literature showed that OTX2 
and OCT4, a transcription factor of the core pluripotency network, bind to similar regulatory 
regions (Yang, et al., 2014).  Previous to that, OTX2 had been shown to be an intrinsic 
determinant of the naïve state, and required for the transition to primed pluripotency 
(Acampora, Di Giovannantonio, & Simeone, 2013). Our data reveals OTX2 as the initial 
determinant controlling the ESC to RSC transition. How OTX2 manages to perform these 
functions is still unknown. This chapter also shows that the demethylation observed in ESCs 
cultured in LIF+2i is caused by the MEK inhibition, and is not an intrinsic attribute of ESCs. This 
finding can have important implications for efficient iPSC derivation from human tissues, as it 
was previously shown that previous somatic epigenetic signature is a limiting factor in iPSC 
derivation efficiency (Gomes, et al., 2017). Indeed, induced demethylation by miR-29b during 
mouse iPSC derivation was shown to increase iPSC quality (Wang, et al., 2017). A potential 
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follow-up on our work could aim at deriving mouse and human iPSCs in the presence of MEK 
inhibition and comparing the efficiency and quality with current state-of-the-art protocols. 
Our findings, in particular coupled with the identification of the RSCs (Chapter 3) will enable 
more studies that need to be done towards the precise identification of OTX2 target genes 
and its protein partners in regulating gene expression at specific timepoints in the ESC-RSC-
EpiSC transition. A thorough time-series experiment combining protein pulldowns with gene 
expression analysis can answer these important questions.  
 To sum up, in this thesis we show that the signaling pathways associated with the 
maintenance and loss of pluripotency (in particular WNT and MEK) have different effects on 
the molecular machinery affecting pluripotency, depending on the particular developmental 
stage of the cells. We enrich the body of evidence demonstrating that ESCs are maintained 
solely by LIF and WNT. In addition, we describe a novel pluripotent state that significantly 
expands our knowledge on stem cell biology and how the balance of different signaling 
pathways affect pluripotency. While pluripotent cells are present in the embryo for a 
significant period of time during the course of development, since 2007 (the year EpiSCs were 
first described), only two pluripotent stem cell types have been described in vitro, limiting our 
view of pluripotency to either naïve ESCs or primed EpiSCs. This indicated that only a limited 
number of stable attractor states can be isolated and stably maintained. This thesis shows that 
a third pluripotent state can be arrested and maintained in culture, and that ESCs and RSCs 
can inter-convert in vitro. Therefore, our proposition is to view pluripotency as a series of 
discrete steps rather than a transitional continuum. Furthermore, modified culture conditions 
can induce novel characteristics in ESCs, RSCs or EpiSCs (for instance, different methylation 
levels), confirming that the functional definition of pluripotency can be fulfilled while 
encompassing a broad spectrum of additional properties. What remains unclear is whether 
bona fide counterparts of the three pluripotency states exist in the human embryo, neither of 
which are trivial questions to answer.  A 2017 paper from the Zernicka-Goetz group indicates 
that to be the case, as they described the lumenogenesis process that occurs in human 
embryos with striking similarities with mouse, without deriving cell lines with RSC features 
(Shahbazi, et al., 2017). Our current knowledge relies on data generated using different types 
of basal media, cytokine combinations (and in different concentrations), functional assays and 
diverse transcriptional analysis platforms, making direct comparisons near impossible. This is 
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eased by embryonic analyses, which make comparisons possible, as well as investigating the 
roles of the various signaling pathways. To understand whether the differences between these 
states are representative of an endogenous developmental progression, one needs to 
determine how each state functionally and transcriptionally relates to another in parallel 
controlled experiments. This needs to be followed by comparisons to high-resolution data 
from the epiblast population of the embryo, through successive stages of embryonic 
development. Ideally, these comparisons would be at a single-cell level, as heterogeneity 
within cell cultures due to asynchronous transitions, as well as in vivo within the epiblast itself, 
may otherwise make the interpretation of these data challenging.  
 The naïve-primed transition is comparable to a reprogramming process that may also 
be reproduced during iPSC generation, as the same factors are involved. In a sense, naïve 
pluripotency is not yet functionally pluripotent. Only primed pluripotent cells can differentiate 
into the germ layers, naïve pluripotency can only become rosette/primed. Understanding this 
process and what enables the embryonic cells to do it so quickly and efficiently may hold 
lessons for understanding and improving reprogramming to induced pluripotency. For 
example, constitutive heterochromatin is a major barrier to iPSC generation, and RSCs simply 
remove it, which may be why they progress so quickly. The work in this thesis lays the 
groundwork to analyze the status of all heterochromatin during the naïve-rosette-primed 
transitions, and investigating whether the silencing of heterochromatin in RSCs is dependent 
on polycomb.  
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Summary 
This thesis aimed to thoroughly describe the effects key signaling pathways have on 
pluripotency, with a particular view towards providing a more complete view of the 
controversy of the role of WNT signaling in pluripotency. Our goal was to investigate how 
different signaling pathways (LIF, WNT and MEK) balance themselves to sustain different 
pluripotent states. 
In Chapter 2 we show that BMP induces differentiation in mouse EpiSCs through a WNT-
independent path to trophoblast, and through a WNT-dependent path to primitive streak. We 
also show that in contrast to ESCs, where WNT maintains naïve pluripotency, in EpiSCs it has 
the opposite effect, triggering differentiation and loss of pluripotency. This demonstrates that 
WNT inhibition maintains EpiSC pluripotency. Moreover, WNT inhibition in EpiSCs promotes a 
profile similar to pre-gastrula epiblast stage, which can lead to blastocyst chimera 
contribution. Lastly, this chapter shows that the inhibition of endogenous WNT signals 
prevents the accumulation of differentiated cells in human ESC cultures.  
In Chapter 3, we demonstrate that WNT signals block lumenogenesis and progression to a 
rosette-like state, while MEK inhibition does not affect this transition but blocks subsequent 
pluripotency progression to the primed state. Moreover, the MEK/WNT-inhibited cells display 
rosette-like features, bivalent marking of primed genes and acquire rosette-specific 
formatting of pericentric heterochromatin. We also show that OTX2 regulates the entry into 
the rosette-like state. The MEK/WNT-inhibited cells represent a novel type of pluripotent cells, 
termed rosette stem cells (RSCs).  
In Chapter 4 we started from the observation that both ESCs and RSCs share a subset of naïve 
pluripotency characteristics, even though WNT activity is on and off, respectively. We asked 
what role does TCF7L1 has in the transition and reversion from naïve to rosette-like and 
showed that Tcf7l1-/- cells inefficiently differentiate to RSCs. Moreover, our data shows that 
WNT activity induces significant changes in the binding pattern of TCF7L1 to protein 
complexes. Whereas the core pluripotency network in ESCs contains OCT4, SOX2, NANOG, 
KLF4 and TCF7L1, the one in RSCs only contains OCT4, SOX2 and TCF7L1, which may explain 
the faster differentiation of the RSCs to EpiSCs. For the first time, we also show that WNT may 
direct Polycomb-mediated repression to genes involved in the transition to the primed state.  
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In Chapter 5, we show that Otx2 is among the first responders to reduced LIF and WNT activity, 
emphasizing its key role in coordinating the transition from naïve to primed pluripotency. In 
addition, we demonstrate that DNA methylation is not a key feature of ESCs, but rather a ‘side-
effect’ of culture caused by MEK inhibition. In addition, we show that the cell motility observed 
in RSCs is repressed by MEK and supported by MEK inhibition.  
In brief, in this thesis I describe a novel pluripotent state that allows an in-depth description 
of the effect different signaling pathways have on the transition from naïve to primed 
pluripotency,  with relevance to the derivation of iPSCs, IVF and oncology.    
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Samenvatting 
Het doel van dit proefschrift was om de effecten van belangrijke signaleringsroutes op de 
pluripotentie grondig te beschrijven, met een visie om een vollediger beeld te krijgen van de 
controverse over de rol van WNT-signalering in pluripotentie. Ons doel was om te 
onderzoeken hoe verschillende signaalwegen (LIF, WNT en MEK) zich in evenwicht houden 
om verschillende pluripotente toestanden te ondersteunen. 
In hoofdstuk 2 laten we zien dat BMP differentiatie induceert in EpiSC's van muizen via een 
WNT-onafhankelijke weg naar trofoblast, en via een WNT-afhankelijke weg naar primitieve 
streak. We laten ook zien dat in tegenstelling tot ESC's, waar WNT naïeve pluripotentie 
handhaaft, het in EpiSC's het tegenovergestelde effect heeft, waardoor differentiatie en 
verlies van pluripotentie wordt veroorzaakt. Dit toont aan dat WNT-remming EpiSC-
pluripotentie handhaaft. Bovendien bevordert de WNT-remming in EpiSC's een profiel 
vergelijkbaar met het pre-gastrula-epiblaststadium, wat kan leiden tot een bijdrage van de 
blastocystchimera. Ten slotte laat dit hoofdstuk zien dat de remming van endogene WNT-
signalen de accumulatie van gedifferentieerde cellen in menselijke ESC-culturen voorkomt. 
In hoofdstuk 3 laten we zien dat WNT signalen de lumenogenese en progressie naar een 
rozetachtige toestand blokkeren, terwijl MEK-remming deze overgang niet beïnvloedt, maar 
de daaropvolgende pluripotentieprogressie naar de geprimede toestand blokkeert. 
Bovendien vertonen de MEK / WNT-geremde cellen rozetachtige kenmerken, bivalente 
markering van geprimede genen en verwerven ze rozet-specifieke opmaak van pericentrisch 
heterochromatine. We laten ook zien dat OTX2 de toegang tot de rozetachtige toestand 
regelt. De MEK / WNT-geremde cellen vertegenwoordigen een nieuw type pluripotente 
cellen, genoemd rozetstamcellen (RSC's). 
In hoofdstuk 4 zijn we uitgegaan van de observatie dat zowel ESC's als RSC's een subset van 
naïeve pluripotentie-eigenschappen delen, hoewel WNT-activiteit respectievelijk aan en uit is. 
We onderzochten welke rol TCF7L1 heeft in de overgang en omkering van naïef naar 
rozetachtig en toonden aan dat Tcf7l1-/- cellen inefficiënt differentiëren tot RSC's. Bovendien 
laat onze data zien dat WNT-activiteit significante veranderingen in het bindingspatroon van 
TCF7L1 aan eiwitcomplexen induceert. Terwijl de kern pluripotentie netwerk in ESC's OCT4, 
SOX2, NANOG, KLF4 en TCF7L1 bevat, bevat dat in RSC's alleen OCT4, SOX2 en TCF7L1, wat de 
snellere differentiatie van de RSC's naar EpiSC's kan verklaren. Voor het eerst laten we ook 
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zien dat WNT door Polycomb gemedieerde repressie kan richten op genen die betrokken zijn 
bij de overgang naar de primer-toestand. 
In hoofdstuk 5 laten we zien dat Otx2 een van de eersten is die op vermindering van LIF- en 
WNT-activiteit reageert, wat zijn sleutelrol benadrukt in de coördinatie van de overgang van 
naïeve naar geprimeerde pluripotentie. Bovendien tonen we aan dat DNA-methylering geen 
belangrijk kenmerk is van ESC's, maar eerder een 'neveneffect' van het kweken veroorzaakt 
door MEK-remming. Bovendien tonen we aan dat de celmotiliteit waargenomen in RSC's 
wordt onderdrukt door MEK en wordt ondersteund door MEK-remming. 
Samengevat,  in dit proefschrift beschrijf ik een nieuwe pluripotente staat die een diepgaande 
beschrijving mogelijk maakt van het effect dat verschillende signaalroutes hebben op de 
overgang van naïeve naar geprimede pluripotentie, met relevantie voor de afleiding van 
iPSC's, IVF en oncologie. 
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